- Home
- ESAB
ESAB
ESAB Corporation
as 03-28-2025 4:00pm EST
| Founded: | 1904 | Country: | United States |
| Employees: | N/A | City: | NORTH BETHESDA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $134.43 | AVG Volume (30 days): | 383.1K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.31 | EPS Growth: | 28.55 |
| 52 Week Low/High: | $88.54 - $135.97 | Next Earning Date: | 04-30-2025 |
| Revenue: | $2,740,803,000 | Revenue Growth: | -1.22% |
| Revenue Growth (this year): | -0.8% | Revenue Growth (next year): | 5.48% |
Stock Insider Trading Activity of ESAB Corporation (ESAB)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Teirlinck Didier P | ESAB | Director | Mar 10 '25 | Sell | $123.48 | 1,611 | $198,926.28 | 0 |
Latest ESAB Corporation News
ESAB Breaking Stock News: Dive into ESAB Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
ESAB: Raising target price to $129.00
StockStory
9 days ago
1 Small-Cap Stock on Our Watchlist and 2 to Avoid
Simply Wall St.
12 days ago
ESAB Corporation's (NYSE:ESAB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
StockStory
12 days ago
3 Reasons to Sell ESAB and 1 Stock to Buy Instead
Argus Research
24 days ago
ESAB: Lowering target price to $123.00
Zacks
a month ago
TriMas Earnings Miss Estimates in Q4, Revenues Increase 9% Y/Y
StockStory
a month ago
Spotting Winners: ESAB (NYSE:ESAB) And Professional Tools and Equipment Stocks In Q4
Business Wire
a month ago
ESAB Corporation Board Declares Dividend
Compare ESAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ESAB ESAB Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.